The clinical impact of rifampicin-based anti-TB therapy and tenofovir alafenamide-containing ARV regimen drug Interaction in people living with HIV: Case series report

• Main Authors: Yahya Ali Mohzari (Author), Mohammed AL Musawa (Author), Ahmad Alrashed (Author), Bandar Zaeri (Author), Nader Damfu (Author), Peter Cahusac (Author), Sana Alwafai (Author), Ahmad Alamer (Author), Abdulaziz Almulhim (Author)
• Format: Book
• Published: Elsevier, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: People living with HIV (PLWH) are prone to developing tuberculosis (TB). Since tenofovir alafenamide (TAF) is the recommended tenofovir (TFV) prodrug and rifampicin is a key component of TB therapy, thus complicating HIV and TB coinfection management. However, there is little data regard...